tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Swedish Orphan Biovitrum AB (GB:0MTD)
LSE:0MTD
UK Market
0MTD
Swedish Orphan Biovitrum AB
RESEARCH TOOLSreports
Advertisement

Swedish Orphan Biovitrum AB (0MTD) Stock News & Sentiment

Compare
3 Followers
Swedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
Premium
Company Announcements
Swedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
13h ago
0MTD
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
Premium
Company Announcements
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
14h ago
0MTD
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
Premium
Company Announcements
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
14h ago
0MTD
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
Premium
Company Announcements
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
15h ago
0MTD
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
Premium
Company Announcements
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
15h ago
0MTD
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
Premium
Company Announcements
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
16h ago
0MTD
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
Premium
Company Announcements
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
17h ago
0MTD
More GB:0MTD News >

0MTD News on the Web

Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
TipRanks News
Neutral
Kepler Capital Keeps Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)
TipRanks News
Neutral
Sobi Revises 2025 Outlook Following Strong Q3 Performance
TipRanks News
Neutral
Swedish Orphan Biovitrum AB (0MTD) Receives a Buy from Berenberg Bank
TipRanks News
Neutral
Sobi Board Approves Share Repurchase for Incentive Program
TipRanks News
Neutral
Berenberg Bank Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)
TipRanks News
Neutral
Kepler Capital Reaffirms Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)
TipRanks News
Neutral
Sobi’s Gamifant Receives FDA Approval for Treating MAS in Still’s Disease
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
GB:0MTD
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0MTD’s Media Buzz Sentiment?
2 articles about GB:0MTD were published this week. In an average week, 1 articles are published.
    What is GB:0MTD’s weekly average amount of articles?
    In an average week, 1 articles about GB:0MTD are published.
      What is GB:0MTD’s News Sentiment?
      50% of articles about GB:0MTD were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        RNAAvidity Biosciences
        UHSUniversal Health
        EHCEncompass Health
        MOHMolina Healthcare
        NBIXNeurocrine
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing